Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Gurewich

Showing results (31-40 of 127) with videos related to

Pageof 13
Sort By:
The New England Journal of Medicine|September 26, 1985
Thrombolytic therapy for acute myocardial infarctionV Gurewich, R Pannell
Journal of Thrombosis and Haemostasis : JTH|June 26, 2016
Structure-function relationships in thrombin-activatable fibrinolysis inhibitor: commentV Gurewich, R Pannell
Thrombosis Research|August 1, 1976
Evaluation of antithrombotic properties of suloctidil in comparison with aspirin and dipyridamoleV Gurewich, B Lipinski
Scandinavian Journal of Haematology|January 1, 1974
The role of fibrin monomer and an in vivo thrombin-induced-anticoagulant in experimental venous thrombosisR Wetmore, V Gurewich
Thrombosis Et Diathesis Haemorrhagica|May 15, 1974
Thrombolysis with streptokinase in rabbits. Dose response, fibrin-clot specificity and laboratory evaluation of fibrinolytic effectA Nowak, V Gurewich
Thrombosis Research|January 1, 1976
Letter: The degradation of soluble versus insoluble fibrin in vivoB Lipinski, V Gurewich
Seminars in Thrombosis and Hemostasis|April 1, 1987
Fibrin binding and zymogenic properties of single-chain urokinase (pro-urokinase)V Gurewich, R Pannell
Archives of Internal Medicine|March 1, 1982
The value of measuring percent high-density lipoprotein in assessing risk of cardiovascular diseaseI Lipinska, V Gurewich
The Journal of Biological Chemistry|June 15, 1993
Substrate inhibition of fibrin-dependent plasminogen activation by tissue-type plasminogen activatorJ Liu, V Gurewich
Blood|March 1, 1987
Inactivation of single-chain urokinase (pro-urokinase) by thrombin and thrombin-like enzymes: relevance of the findings to the interpretation of fibrin-binding experimentsV Gurewich, R Pannell
Pageof 13

Showing results (31-40 of 127) with videos related to

Sort By:
Pageof 13
The New England Journal of Medicine|September 26, 1985
Thrombolytic therapy for acute myocardial infarctionV Gurewich, R Pannell
Journal of Thrombosis and Haemostasis : JTH|June 26, 2016
Structure-function relationships in thrombin-activatable fibrinolysis inhibitor: commentV Gurewich, R Pannell
Thrombosis Research|August 1, 1976
Evaluation of antithrombotic properties of suloctidil in comparison with aspirin and dipyridamoleV Gurewich, B Lipinski
Scandinavian Journal of Haematology|January 1, 1974
The role of fibrin monomer and an in vivo thrombin-induced-anticoagulant in experimental venous thrombosisR Wetmore, V Gurewich
Thrombosis Et Diathesis Haemorrhagica|May 15, 1974
Thrombolysis with streptokinase in rabbits. Dose response, fibrin-clot specificity and laboratory evaluation of fibrinolytic effectA Nowak, V Gurewich
Thrombosis Research|January 1, 1976
Letter: The degradation of soluble versus insoluble fibrin in vivoB Lipinski, V Gurewich
Seminars in Thrombosis and Hemostasis|April 1, 1987
Fibrin binding and zymogenic properties of single-chain urokinase (pro-urokinase)V Gurewich, R Pannell
Archives of Internal Medicine|March 1, 1982
The value of measuring percent high-density lipoprotein in assessing risk of cardiovascular diseaseI Lipinska, V Gurewich
The Journal of Biological Chemistry|June 15, 1993
Substrate inhibition of fibrin-dependent plasminogen activation by tissue-type plasminogen activatorJ Liu, V Gurewich
Blood|March 1, 1987
Inactivation of single-chain urokinase (pro-urokinase) by thrombin and thrombin-like enzymes: relevance of the findings to the interpretation of fibrin-binding experimentsV Gurewich, R Pannell
Pageof 13